View
Featured Blog Post
Companion Diagnostics Explained: Their Critical Role in Cancer Care and Our Latest Approvals
When oncologists are treating advanced cancer patients, they need to move quickly from insight to action. To do so, they need comprehensive, reliable information about what is driving a patient’s cancer so they can make personalized treatment decisions. We’ve forged a path forward to achieve the highest quality standards for our tests – to both improve adoption of comprehensive genomic profiling (CGP) and access to this technology in the clinic.
From the Foundation Forward Blog
-
August 03, 2021
Making Comprehensive Genomic Profiling Indispensable at a Global Level: Progress, Perspectives and What’s Next | Foundation Medicine
-
July 15, 2021
Companion Diagnostics Explained: Their Critical Role in Cancer Care and Our Latest Approvals | Foundation Medicine
-
June 23, 2021
The Promise and Potential of Genomic Data for the Future of Precision Medicine | Foundation Medicine
-
April 12, 2021
As Genomic Profiling Becomes Standard of Care, Real-World Genomic Data Comes of Age | Foundation Medicine
-
February 27, 2021
Comprehensive Genomic Profiling as the Driver of Change in Rarer Cancers | Foundation Medicine